Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy
ChatGPT-4 not reliable in cancer patient messaging
By
Amerigo Allegretto
ChatGPT-4 is not a reliable source for answering patients’ questions regarding cancer and needs physician monitoring.
April 25, 2024
The rise of theranostics: Part 2 -- Moving into communities
By
Liz Carey
In part 2 of The Rise of theranostics series, experts weigh in on getting started in prostate cancer theranostics as some private urology, radiation oncology practices, and radiologist groups begin building their abilities.
April 4, 2024
The rise of theranostics: Part 1 -- Gaining momentum
By
Liz Carey
FDA-approved radiopharmaceuticals have energized the field of theranostics. In part 1 of a series, experienced theranostics leaders offer implications of the latest clinical trials, how a theranostics clinic works, and advice for introducing theranostics.
March 26, 2024
Researcher outlines radiation oncology workforce challenges
By
Amerigo Allegretto
Arya Amini, MD, spoke with
AuntMinnie.com
about a paper he co-authored that outlines workforce challenges being faced by radiation oncologists.
February 23, 2024
PET/CT radiomics predicts outcomes in women with cervical cancer
By
Will Morton
A radiomics nomogram based on F-18 FDG-PET/CT imaging could help clinicians assess long-term outcomes in women undergoing treatment for locally advanced cervical cancer.
February 2, 2024
PSMA-PET helps plan treatment in men with relapsed prostate cancer
By
Will Morton
PSMA-PET led to management changes in one-third of men receiving salvage radiotherapy for prostate cancer that recurred after radical prostatectomy.
January 31, 2024
FAPI-PET shows promise in head and neck cancer patients
By
Will Morton
In a comparative imaging trial, FAPI-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer.
January 26, 2024
TerraPower distributes first shipments of Ac-225
By
AuntMinnie.com staff writers
TerraPower Isotopes has shipped its first samples of Actinium-225 (Ac-225) to two pharmaceutical companies to develop targeted cancer treatments in drug trials.
January 24, 2024
FAPI-PET outperforms FDG-PET in diagnosing pancreatic cancer
By
Will Morton
F-18 FAPI-PET/CT is superior to F-18 FDG-PET/CT for diagnosing and staging patients with pancreatic cancer.
January 5, 2024
PET/CT scans ‘crucial’ in patients with NK/T-cell lymphoma
By
Will Morton
PET/CT has significant advantages over conventional methods for lesion detection and staging in patients with natural killer/T-cell lymphoma.
December 22, 2023
FES-PET better than FDG-PET in breast cancer patients
By
Will Morton
In a head-to-head comparison, F-18 fluoroestradiol (FES)-PET/CT was better than standard FDG-PET/CT for the initial staging of estrogen receptor-positive breast cancer patients.
December 21, 2023
NorthStar to end production of Mo-99
By
Will Morton
NorthStar Medical Radioisotopes will shut down its molybdenum-99 (Mo-99) production facilities in Beloit, WI, by the end of 2023.
October 9, 2023
Page 1 of 461
Next Page